[1-(2-{1-[(1-ethyl-1H-pyrazol-4-yl)methyl]piperidin-2-yl}ethyl)-1H-1,2,3-triazol-4-yl](morpholin-4-yl)methanone
Chemical Structure Depiction of
[1-(2-{1-[(1-ethyl-1H-pyrazol-4-yl)methyl]piperidin-2-yl}ethyl)-1H-1,2,3-triazol-4-yl](morpholin-4-yl)methanone
[1-(2-{1-[(1-ethyl-1H-pyrazol-4-yl)methyl]piperidin-2-yl}ethyl)-1H-1,2,3-triazol-4-yl](morpholin-4-yl)methanone
Compound characteristics
| Compound ID: | T505-1091 |
| Compound Name: | [1-(2-{1-[(1-ethyl-1H-pyrazol-4-yl)methyl]piperidin-2-yl}ethyl)-1H-1,2,3-triazol-4-yl](morpholin-4-yl)methanone |
| Molecular Weight: | 401.51 |
| Molecular Formula: | C20 H31 N7 O2 |
| Smiles: | CCn1cc(CN2CCCCC2CCn2cc(C(N3CCOCC3)=O)nn2)cn1 |
| Stereo: | RACEMIC MIXTURE |
| logP: | 0.2609 |
| logD: | -5.5828 |
| logSw: | -0.319 |
| Hydrogen bond acceptors count: | 7 |
| Polar surface area: | 69.333 |
| InChI Key: | AZAVZQOMDOVYQT-GOSISDBHSA-N |